Select Page

Restoring Lung Function With Nanotechnology

OUR MISSION

Lung Therapy For ARDS

Acute respiratory distress syndrome (ARDS) is a life-threatening lung injury that allows fluid to leak into the lungs. Breathing becomes difficult and oxygen cannot get into the body. Most people who get ARDS are already at the hospital for trauma or illness.

Our mission is to providing lung restoration to babies suffering
from ARDS by using new proprietary methods

OUR SOLUTION

A First-In-Kind, Polymer Lung Surfactant (PLS)

  • Low complexity synthesis and formulation
  • Interface affinity exceeds competing agents
  • Reduces alveolar surface tension and fluid accumulation

OUR JOURNEY

MILESTONES

MEET OUR TEAM

Rich Ganz - CEO

30+ years of life science industry experience

Davis Arrick - CEO

4 years of manufacturing industry experience

You-Yeon Won - CSO

10 years developing novel nanomedicine tech

ADVISORS

Arindam Bose, PhD

Purdue University, Former VP at Pfizer, Member of National Academy of Engineers

Wade Lange, MS

Purdue University, Former President/CEO Immune Works

COLLABORATORS

Krishan Raghavendran, MD

University of Michigan, Division Chief of Acute Care Surgery

Perenlei Enkhbaatar, MD, PhD

University of Texas Medical Branch, Director of Anesthesiology and Translational ICU Professor

CONTACT US

Help us make real world change. Please fill out this form below.